BCRX icon

BioCryst Pharmaceuticals

124 hedge funds and large institutions have $740M invested in BioCryst Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 43 increasing their positions, 41 reducing their positions, and 21 closing their positions.

Holders
124
Holders Change
+1
Holders Change %
+0.81%
% of All Funds
3.47%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
22
Increased
43
Reduced
41
Closed
21
Calls
$16.4M
Puts
$6.5M
Net Calls
+$9.86M
Net Calls Change
+$10.8M
Name Market Value Shares Shares
Change
Shares
Change %
HCM
126
Highbridge Capital Management
New York
-137,042 Closed
Balyasny Asset Management
127
Balyasny Asset Management
Illinois
-87,111 Closed
AL
128
Airain Ltd
Guernsey
-76,498 Closed
PP
129
PDT Partners
New York
-74,960 Closed
SI
130
Standard Investments
New York
-73,500 Closed
NCCM
131
Nine Chapters Capital Management
New Jersey
-43,600 Closed
QSS
132
Quantitative Systematic Strategies
Florida
-41,609 Closed
CSS
133
Cubist Systematic Strategies
Connecticut
-38,290 Closed
TMC
134
Trellus Management Company
Florida
-18,700 Closed
VAM
135
Visium Asset Management
New York
-15,300 Closed
DTL
136
Dynamic Technology Lab
Singapore
-14,397 Closed
BCA
137
Burren Capital Advisors
Gibraltar
-13,900 Closed
EMG
138
Ellington Management Group
Connecticut
-11,719 Closed
HF
139
HRT Financial
New York
-10,973 Closed
SCM
140
Stevens Capital Management
Pennsylvania
-10,679 Closed
SG Americas Securities
141
SG Americas Securities
New York
-8,031 Closed
ASN
142
Advisory Services Network
Georgia
-7,303 Closed
QT
143
Quantbot Technologies
New York
-6,759 Closed
TRCT
144
Tower Research Capital (TRC)
New York
-4,673 Closed
Point72 Asset Management
145
Point72 Asset Management
Connecticut
-2,000 Closed
Jane Street
146
Jane Street
New York
ST
147
Spot Trading
Illinois
Simplex Trading
148
Simplex Trading
Illinois